Skip to content
2000
Volume 12, Issue 1
  • ISSN: 1875-6921
  • E-ISSN: 1875-6913

Abstract

The inter-patient differences in drug response is documented to be attributable to heritable genetic variations in the nucleotide sequence of drug-metabolizing enzymes. The identification of variant allele frequencies in specific ethnic groups is important to individualize drug dosing and improve therapeutics. This study aimed to detect single-nucleotide polymorphism (SNP) in CYP3A4 and the homozygous deletion (0/0) of GSTM1 and GSTT1 in a Filipino population. Onehundred and forty-two Filipino subjects were genotyped for the CYP3A4*18 SNP using PCR-RFLP and the GSTM1 0/0 and GSTT1 0/0 by basic PCR followed by agarose gel electrophoresis. In the study population, the frequency of the CYP3A4*18 variant allele was found to be 2.11%. The percentage of GSTM1 0/0 observed was 64.08 while that of GSTT1 0/0 was 48.59. These frequencies complement studies in other Asian populations highlighting the importance of the screening for future prospects of individualized medicines.

Loading

Article metrics loading...

/content/journals/cppm/10.2174/187569211201140610122555
2014-05-01
2025-10-31
Loading full text...

Full text loading...

/content/journals/cppm/10.2174/187569211201140610122555
Loading

  • Article Type:
    Research Article
Keyword(s): CYP3A4*18; drug metabolism; gene polymorphisms; GSTM1; GSTT1
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test